Literature DB >> 10875807

Treatment of early Parkinson's disease.

L Marsh, T M Dawson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875807      PMCID: PMC1127674          DOI: 10.1136/bmj.321.7252.1

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

Authors:  O Rascol; D J Brooks; A D Korczyn; P P De Deyn; C E Clarke; A E Lang
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

Review 2.  An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology.

Authors:  C W Olanow; W C Koller
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

Review 3.  Levodopa therapy: consequences of the nonphysiologic replacement of dopamine.

Authors:  T N Chase
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

Review 4.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  L Marsh
Journal:  Psychosomatics       Date:  2000 Jan-Feb       Impact factor: 2.386

5.  Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.

Authors:  O Rascol; D J Brooks; E R Brunt; A D Korczyn; W H Poewe; F Stocchi
Journal:  Mov Disord       Date:  1998-01       Impact factor: 10.338

Review 6.  Should treatment of Parkinson's disease be started with a dopamine agonist?

Authors:  W Poewe
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

  6 in total
  11 in total

1.  Research methods used in developing and applying quality indicators in primary care.

Authors:  S M Campbell; J Braspenning; A Hutchinson; M Marshall
Journal:  Qual Saf Health Care       Date:  2002-12

Review 2.  Hard work never hurt anyone--or did it? A review of occupational associations with soft tissue musculoskeletal disorders of the neck and upper limb.

Authors:  K Walker-Bone; C Cooper
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

Review 3.  Hard work never hurt anyone: or did it? A review of occupational associations with soft tissue musculoskeletal disorders of the neck and upper limb.

Authors:  K Walker-Bone; C Cooper
Journal:  Ann Rheum Dis       Date:  2005-10       Impact factor: 19.103

4.  [Quality management in regional anesthesia using the example of a Regional Anesthesia Surveillance System (RASS)].

Authors:  S Schulz-Stübner; M Czaplik
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

Review 5.  Primary care mental health workers: models of working and evidence of effectiveness.

Authors:  Peter Bower
Journal:  Br J Gen Pract       Date:  2002-11       Impact factor: 5.386

Review 6.  [Epidural anesthesia].

Authors:  F Gerheuser; A Roth
Journal:  Anaesthesist       Date:  2007-05       Impact factor: 1.041

Review 7.  Levodopa alone compared with levodopa-sparing therapy as initial treatment for Parkinson's disease: a meta-analysis.

Authors:  Cheng-long Xie; Yun-Yun Zhang; Xiao-Dan Wang; Jie Chen; Yi-He Chen; Jia-Lin Pa; Shi-Yi Lin; Hua-Zhen Lin; Wen-Wen Wang
Journal:  Neurol Sci       Date:  2015-05-17       Impact factor: 3.307

Review 8.  [Perioperative care of patients with diastolic heart failure. Interface to anesthesia].

Authors:  S Heschl; C Colantonio; B Pieske; W Toller
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

9.  [Locoregional anesthesia and coagulation inhibitors. Recommendations of the Task Force on Perioperative Coagulation of the Austrian Society for Anesthesiology and Intensive Care Medicine].

Authors:  S A Kozek-Langenecker; D Fries; M Gütl; N Hofmann; P Innerhofer; W Kneifl; L Neuner; P Perger; T Pernerstorfer; G Pfanner; H Schöchl
Journal:  Anaesthesist       Date:  2005-05       Impact factor: 1.041

Review 10.  [Circumcision and orchiopexy: management of complications].

Authors:  M Promm; W H Rösch
Journal:  Urologe A       Date:  2014-05       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.